META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
1d agoen
From the article
Conditions : Autoimmune Hemolytic Anemia (AIHA) Interventions : Biological: Metabolically Armed Autologous CD19 CAR T-Cell therapy Sponsors : Institute of Hematology & Blood Diseases Hospital, China; Hangzhou Leman Biotech Co., Ltd Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Resetting autoimmune disease with CAR cell therapies
doi.org·14d ago
Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus
This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce
lupus.bmj.com·26d agoDeep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
doi.org·13d ago
Biohacker Bryan Johnson diagnosed with incurable autoimmune gastritis after years of anti-aging treatments
Tech entrepreneur Bryan Johnson, who spends over $2 million annually on anti-aging treatments including blood transfusions from his teenage
lifesitenews.com·12h ago
OHSU logra un gran avance en la ciencia médica con las terapias celulares
Oregon Health & Sciences University·12d ago
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ (ofatumumab) in advanced stage blood cancer
GSK·17y ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.